HL7 Terminology (THO)
6.1.0 - Publication International flag

This page is part of the HL7 Terminology (v6.1.0: Release) based on FHIR (HL7® FHIR® Standard) v5.0.0. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

ValueSet: LogicalObservationIdentifierNamesAndCodes

Official URL: http://terminology.hl7.org/ValueSet/v3-LogicalObservationIdentifierNamesAndCodes Version: 3.0.0
Active as of 2014-03-26 Responsible: Health Level Seven International Computable Name: LogicalObservationIdentifierNamesAndCodes
Other Identifiers: OID:2.16.840.1.113883.1.11.16492

Copyright/Legal: This material derives from the HL7 Terminology THO. THO is copyright ©1989+ Health Level Seven International and is made available under the CC0 designation. For more licensing information see: https://terminology.hl7.org/license.html

The LOINC database provides a set of universal names and ID codes for identifying laboratory and clinical test results. The purpose is to facilitate the exchange and pooling of results, such as blood hemoglobin, serum potassium, or vital signs, for clinical care, outcomes management, and research. The LOINC codes are not intended to transmit all possible information about a test or observation. They are only intended to identify the test result or clinical observation. http://www.regenstrief.org/LOINC/LOINC.htm

References

Logical Definition (CLD)

Generated Narrative: ValueSet v3-LogicalObservationIdentifierNamesAndCodes

Language: en

 

Expansion

Generated Narrative: ValueSet

Language: en

Expansion based on Loinc v2.78

This value set has >1000 codes in it. In order to keep the publication size manageable, only a selection (1000 codes) of the whole set of codes is shown

CodeSystemDisplay - English (English, en)
  100000-9http://loinc.orgHealth informatics pioneer and the father of LOINC
  100001-7http://loinc.orgHealth informatics pioneer and cofounder of LOINC
  100002-5http://loinc.orgSpecimen care is maintained
  100003-3http://loinc.orgTeam communication is maintained throughout care
  100004-1http://loinc.orgDemonstrates knowledge of the expected psychosocial responses to the procedure
  100005-8http://loinc.orgDemonstrates knowledge of nutritional management related to the procedure
  100006-6http://loinc.orgDemonstrates knowledge of medication management
  100007-4http://loinc.orgDemonstrates knowledge of pain management
  10000-8http://loinc.orgR wave duration in lead AVR
  100008-2http://loinc.orgDemonstrates knowledge of wound management
  100009-0http://loinc.orgDemonstrates knowledge of the procedure and expected results
  100010-8http://loinc.orgNo injury related to procedure equipment, medical supplies, or instrumentation
  100011-6http://loinc.orgNo injury related to an electrical source
  100012-4http://loinc.orgParticipates in decisions affecting the patient's plan of care
  100013-2http://loinc.orgParticipates in the discharge process
  100014-0http://loinc.orgPsychosocial health is maintained at or improved from baseline
  100015-7http://loinc.orgNo injury related to positioning due to care or procedure
  10001-6http://loinc.orgR wave duration in lead I
  100016-5http://loinc.orgNo injury related to a laser source
  100017-3http://loinc.orgPerioperative nursing data set outcomes panel [PNDS]
  100018-1http://loinc.orgHospice care Note
  100019-9http://loinc.orgALK gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100020-7http://loinc.orgGNA11 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100021-5http://loinc.orgGNAQ gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100022-3http://loinc.orgIDH1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100023-1http://loinc.orgIDH2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  10002-4http://loinc.orgR wave duration in lead II
  100024-9http://loinc.orgSETBP1 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100025-6http://loinc.orgSRSF2 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100026-4http://loinc.orgMET gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100027-2http://loinc.orgSMAD4 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100028-0http://loinc.orgFBXW7 gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
  100029-8http://loinc.orgCancer related multigene analysis in Plasma cell-free DNA by Molecular genetics method
  100030-6http://loinc.orgAxis I: Temporal aspects score [Mainz Pain Staging System]
  100031-4http://loinc.orgAxis II: Spatial aspects score [Mainz Pain Staging System]
  10003-2http://loinc.orgR wave duration in lead III
  100032-2http://loinc.orgAxis III: Drug taking behavior score [Mainz Pain Staging System]
  100033-0http://loinc.orgAxis IV: Utilization of the health care system score [Mainz Pain Staging System]
  100034-8http://loinc.orgProvider of automated external defibrillator use
  100035-5http://loinc.orgExam finding location of Chest
  100036-3http://loinc.orgExam finding location of Lung
  100037-1http://loinc.orgPatient contact disposition EMS unit
  100038-9http://loinc.orgPatient evaluation disposition EMS unit
  100039-7http://loinc.orgCrew disposition for patient care EMS unit
  10004-0http://loinc.orgR wave duration in lead V1
  100040-5http://loinc.orgPatient transport disposition EMS unit
  100041-3http://loinc.orgAminoglycoside [Susceptibility]
  100042-1http://loinc.orgAtovaquone [Susceptibility]
  100043-9http://loinc.orgAzithromycin+Ethambutol [Susceptibility]
  100044-7http://loinc.orgCefcapene [Susceptibility]
  100045-4http://loinc.orgCefozopran [Susceptibility]
  100046-2http://loinc.orgCefquinome [Susceptibility]
  100047-0http://loinc.orgCefteram [Susceptibility]
  100048-8http://loinc.orgClarithromycin+Ethambutol [Susceptibility]
  100049-6http://loinc.orgEravacycline [Susceptibility]
  100050-4http://loinc.orgErythromycin+Ethambutol [Susceptibility]
  100051-2http://loinc.orgEthambutol+rifAMPin [Susceptibility]
  100052-0http://loinc.orgFlomoxef [Susceptibility]
  100053-8http://loinc.orgFluoroquinolone [Susceptibility]
  100054-6http://loinc.orgGamithromycin [Susceptibility]
  100055-3http://loinc.orgOptochin [Susceptibility]
  100056-1http://loinc.orgPanipenem [Susceptibility]
  10005-7http://loinc.orgR wave duration in lead V2
  100057-9http://loinc.orgProthionamide [Susceptibility]
  100058-7http://loinc.orgPrulifloxacin [Susceptibility]
  100059-5http://loinc.orgRifapentine [Susceptibility]
  100060-3http://loinc.orgTildipirosin [Susceptibility]
  100061-1http://loinc.orgTosufloxacin [Susceptibility]
  100062-9http://loinc.orgStandard Dermatology Outcome Measures panel
  100063-7http://loinc.orgPrimary skin concern
  100064-5http://loinc.orgItch severity Reporting Period - Reported
  10006-5http://loinc.orgR wave duration in lead V3
  100065-2http://loinc.orgSatisfied with treatment
  100066-0http://loinc.orgSpecular microscopy panel
  100067-8http://loinc.orgEye Image magnification
  100068-6http://loinc.orgRight eye Fixation point [Angle]
  100069-4http://loinc.orgLeft eye Fixation point [Angle]
  100070-2http://loinc.orgRight cornea Cell density
  100071-0http://loinc.orgLeft cornea Cell density
  100072-8http://loinc.orgRight cornea Coefficient of variation
  10007-3http://loinc.orgR wave duration in lead V4
  100073-6http://loinc.orgLeft cornea Coefficient of variation
  100074-4http://loinc.orgRight cornea Hexagonality
  100075-1http://loinc.orgLeft cornea Hexagonality
  100076-9http://loinc.orgRight cornea Endothelial cells counted
  100077-7http://loinc.orgLeft cornea Endothelial cells counted
  100078-5http://loinc.orgRight cornea Endothelial cell area.min
  100079-3http://loinc.orgLeft cornea Endothelial cell area.min
  100080-1http://loinc.orgRight cornea Endothelial cell area.max
  10008-1http://loinc.orgR wave duration in lead V5
  100081-9http://loinc.orgLeft cornea Endothelial cell area.max
  100082-7http://loinc.orgRight cornea Endothelial cell area.mean
  100083-5http://loinc.orgLeft cornea Endothelial cell area.mean
  100084-3http://loinc.orgRight cornea Cell area.standard deviation
  100085-0http://loinc.orgLeft cornea Cell area.standard deviation
  100086-8http://loinc.orgRight cornea Type of Analysis method by Specular microscopy
  100087-6http://loinc.orgToxocara canis 24-35kD IgG Ab [Presence] in Serum by Immunoblot
  100088-4http://loinc.orgTaenia solium larva Ab bands panel - Serum by Immunoblot
  100089-2http://loinc.orgTaenia solium larva 6-8kD Ab [Presence] in Serum by Immunoblot
  1000-9http://loinc.orgDBG Ab [Presence] in Serum or Plasma from Blood product unit
  100090-0http://loinc.orgTaenia solium larva 45kD Ab [Presence] in Serum by Immunoblot
  100091-8http://loinc.orgTrypanosoma cruzi Ab [Units/volume] in Serum by Immunoassay
  100092-6http://loinc.orgTrypanosoma cruzi Ab bands panel - Serum by Immunoblot
  100093-4http://loinc.orgTrypanosoma cruzi 15-16kD IgG Ab [Presence] in Serum by Immunoblot
  100094-2http://loinc.orgTrypanosoma cruzi 21-22kD IgG Ab [Presence] in Serum by Immunoblot
  100095-9http://loinc.orgTrypanosoma cruzi 27-28kD IgG Ab [Presence] in Serum by Immunoblot
  100096-7http://loinc.orgTrypanosoma cruzi 42kD IgG Ab [Presence] in Serum by Immunoblot
  100097-5http://loinc.orgTrypanosoma cruzi 45-47kD IgG Ab [Presence] in Serum by Immunoblot
  100098-3http://loinc.orgTrypanosoma cruzi 120-200kD IgG Ab [Presence] in Serum by Immunoblot
  10009-9http://loinc.orgR wave duration in lead V6
  100099-1http://loinc.orgTrypanosoma cruzi 160kD IgG Ab [Presence] in Serum by Immunoblot
  100100-7http://loinc.orgFasciola sp IgG Ab [Presence] in Serum by Immunoassay
  100101-5http://loinc.orgFasciola sp 8-9kD IgG Ab [Presence] in Serum by Immunoblot
  100102-3http://loinc.orgFasciola sp 27-28kD IgG Ab [Presence] in Serum by Immunoblot
  100103-1http://loinc.orgFasciola sp 60kD IgG Ab [Presence] in Serum by Immunoblot
  100104-9http://loinc.orgFasciola sp 42kD IgG Ab [Presence] in Serum by Immunoblot
  100105-6http://loinc.orgFilaria IgG and IgM panel - Serum
  100106-4http://loinc.orgFilaria IgG Ab [Presence] in Serum by Immunoassay
  10010-7http://loinc.orgR' wave amplitude in lead AVF
  100107-2http://loinc.orgLeishmania sp IgG Ab [Presence] in Serum by Immunoassay
  100108-0http://loinc.orgLeishmania sp IgG Ab [Units/volume] in Serum by Immunoassay
  100109-8http://loinc.orgLeishmania sp Ab bands panel - Serum by Immunoblot
  100110-6http://loinc.orgLeishmania sp 14kD IgG Ab [Presence] in Serum by Immunoblot
  100111-4http://loinc.orgLeishmania sp 16kD IgG Ab [Presence] in Serum by Immunoblot
  100112-2http://loinc.orgFasciola sp Ab bands panel - Serum by Immunoblot
  100113-0http://loinc.orgHelicobacter pylori Ab panel - Serum
  100114-8http://loinc.orgToxoplasma gondii 30kD Ab [Presence] in Serum by Immunoblot
  10011-5http://loinc.orgR' wave amplitude in lead AVL
  100115-5http://loinc.orgToxoplasma gondii 31kD Ab [Presence] in Serum by Immunoblot
  100116-3http://loinc.orgToxoplasma gondii 33kD Ab [Presence] in Serum by Immunoblot
  100117-1http://loinc.orgToxoplasma gondii 40kD Ab [Presence] in Serum by Immunoblot
  100118-9http://loinc.orgToxoplasma gondii 41kD Ab [Presence] in Serum by Immunoblot
  100119-7http://loinc.orgToxoplasma gondii 45kD Ab [Presence] in Serum by Immunoblot
  100120-5http://loinc.orgChlamydia trachomatis Ab panel - Serum
  100121-3http://loinc.orgChlamydia trachomatis IgA Ab [Presence] in Serum by Immunoassay
  100122-1http://loinc.orgChlamydophila pneumoniae Ab panel - Serum
  10012-3http://loinc.orgR' wave amplitude in lead AVR
  100123-9http://loinc.orgChlamydophila pneumoniae IgA Ab [Presence] in Serum by Immunoassay
  100124-7http://loinc.orgChlamydophila pneumoniae IgA Ab [Units/volume] in Serum by Immunoassay
  100125-4http://loinc.orgChlamydophila psittaci Ab panel - Serum
  100126-2http://loinc.orgBordetella pertussis Ab.IgG panel - Serum
  100127-0http://loinc.orgCampylobacter sp Ab panel - Serum
  100128-8http://loinc.orgCryptococcus sp Ag panel - Serum
  100129-6http://loinc.orgSchistosoma sp Ab [Titer] in Serum by Hemagglutination
  100130-4http://loinc.orgSchistosoma mansoni Ab [Presence] in Serum by Immunoblot
  10013-1http://loinc.orgR' wave amplitude in lead I
  100131-2http://loinc.orgSchistosoma sp 8kD Ab [Presence] in Serum by Immunoblot
  100132-0http://loinc.orgSchistosoma sp 9kD Ab [Presence] in Serum by Immunoblot
  100133-8http://loinc.orgSchistosoma sp 10kD Ab [Presence] in Serum by Immunoblot
  100134-6http://loinc.orgSchistosoma sp 11kD Ab [Presence] in Serum by Immunoblot
  100135-3http://loinc.orgSchistosoma sp 12-13kD Ab [Presence] in Serum by Immunoblot
  100136-1http://loinc.orgSchistosoma sp 14-15kD Ab [Presence] in Serum by Immunoblot
  100137-9http://loinc.orgSchistosoma sp 15-16kD Ab [Presence] in Serum by Immunoblot
  100138-7http://loinc.orgSchistosoma sp 18-19kD Ab [Presence] in Serum by Immunoblot
  100139-5http://loinc.orgSchistosoma sp 22-24kD Ab [Presence] in Serum by Immunoblot
  100140-3http://loinc.orgSchistosoma sp 30-34kD Ab [Presence] in Serum by Immunoblot
  100141-1http://loinc.orgSchistosoma sp 65kD Ab [Presence] in Serum by Immunoblot
  100142-9http://loinc.orgSchistosoma sp 70kD Ab [Presence] in Serum by Immunoblot
  100143-7http://loinc.orgSchistosoma sp 80kD Ab [Presence] in Serum by Immunoblot
  100144-5http://loinc.orgSchistosoma sp 95kD Ab [Presence] in Serum by Immunoblot
  100145-2http://loinc.orgSchistosoma sp 110kD Ab [Presence] in Serum by Immunoblot
  100146-0http://loinc.orgSchistosoma sp 120kD Ab [Presence] in Serum by Immunoblot
  100147-8http://loinc.orgToxoplasma gondii Ab bands panel - Serum by Immunoblot
  100148-6http://loinc.orgSchistosoma sp Ab bands panel - Serum by Immunoblot
  10014-9http://loinc.orgR' wave amplitude in lead II
  100149-4http://loinc.org6-oxo-piperidine-2-carboxylate and 6(R+S)-oxo-propylpiperidine-2-carboxylate panel - Urine and Serum or Plasma
  100150-2http://loinc.org6(R+S)-oxo-propylpiperidine-2-carboxylate [Moles/volume] in Plasma
  100151-0http://loinc.org6-oxo-piperidine-2-carboxylate [Moles/volume] in Plasma
  100152-8http://loinc.org6-oxo-piperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
  100153-6http://loinc.org6(R+S)-oxo-propylpiperidine-2-carboxylate/Creatinine [Molar ratio] in Urine
  100154-4http://loinc.orgSpecimen collection supervision level
  100155-1http://loinc.orgLeft cornea Type of Analysis method by Specular microscopy
  10015-6http://loinc.orgR' wave amplitude in lead III
  100156-9http://loinc.orgSARS-CoV-2 (COVID-19) variant [Type] in Specimen by NAA with probe detection
  100157-7http://loinc.orgSARS-CoV-2 (COVID-19) lineage [Type] in Specimen by Sequencing
  100158-5http://loinc.orgMicroalbumin [Mass/volume] in Urine collected for unspecified duration
  100159-3http://loinc.orgKnee Society Score pre-op panel [Knee Society Score]
  100160-1http://loinc.orgKnee replacement
  100161-9http://loinc.orgCharnley Functional Classification
  100162-7http://loinc.orgKnee alignment W standing X-ray measured
  100163-5http://loinc.orgKnee medial AndOr lateral instability W full extension
  10016-4http://loinc.orgR' wave amplitude in lead V1
  100164-3http://loinc.orgKnee AP instability W 90 degree flexion
  100165-0http://loinc.orgKnee range of motion
  100166-8http://loinc.orgFlexion contracture range of Knee
  100167-6http://loinc.orgExtensor lag range of Knee
  100168-4http://loinc.orgKnee pain severity with level walking
  100169-2http://loinc.orgKnee pain severity with stairs or inclines
  1001-7http://loinc.orgDBG Ab [Presence] in Serum or Plasma from Donor
  100170-0http://loinc.orgKnee feels normal
  100171-8http://loinc.orgSatisfaction with level of knee pain while sitting
  10017-2http://loinc.orgR' wave amplitude in lead V2
  100172-6http://loinc.orgSatisfaction with level of knee pain while lying in bed
  100173-4http://loinc.orgSatisfaction with knee function while getting out of bed
  100174-2http://loinc.orgSatisfaction with knee function while performing light household duties
  100175-9http://loinc.orgSatisfaction with knee function while performing recreational activities
  100176-7http://loinc.orgExpect surgery to relieve pain
  100177-5http://loinc.orgExpect surgery will improve ability to perform activities of daily living
  100178-3http://loinc.orgExpect surgery will improve ability to perform leisure, recreational, or sports activities
  100179-1http://loinc.orgWalk without assistive mobility devices
  10018-0http://loinc.orgR' wave amplitude in lead V3
  100180-9http://loinc.orgAssistive mobility devices used
  100181-7http://loinc.orgAssistive mobility devices used due to health condition
  100182-5http://loinc.orgDuration of standing before sitting due to knee discomfort
  100183-3http://loinc.orgDuration of walking before stopping due to knee discomfort
  100184-1http://loinc.orgHow bothersome is knee when walking on an uneven surface
  100185-8http://loinc.orgHow bothersome is knee when turning or pivoting leg
  100186-6http://loinc.orgHow bothersome is knee when climbing up or down a flight of stairs
  100187-4http://loinc.orgHow bothersome is knee when getting up from a low seat without armrests
  100188-2http://loinc.orgHow bothersome is knee when getting into or out of a car
  100189-0http://loinc.orgHow bothersome is knee when moving laterally
  100190-8http://loinc.orgHow bothersome is knee when climbing a ladder or step stool
  100191-6http://loinc.orgHow bothersome is knee when carrying a bag for one block
  100192-4http://loinc.orgHow bothersome is knee when squatting
  100193-2http://loinc.orgHow bothersome is knee when kneeling
  100194-0http://loinc.orgHow bothersome is knee when running
  100195-7http://loinc.orgPain severity--during activity
  100196-5http://loinc.orgPre-op total score [Knee Society Score]
  100197-3http://loinc.orgExercise activity and pain severity panel
  10019-8http://loinc.orgR' wave amplitude in lead V4
  100198-1http://loinc.orgPre-op objective knee indicators score [Knee Society Score]
  100199-9http://loinc.orgPre-op symptoms score [Knee Society Score]
  100200-5http://loinc.orgPre-op patient expectations score [Knee Society Score]
  100201-3http://loinc.orgPre-op functional activities score [Knee Society Score]
  100202-1http://loinc.orgPre-op discretionary knee activities score [Knee Society Score]
  100203-9http://loinc.orgKnee Society Score post-op panel [Knee Society Score]
  100204-7http://loinc.orgAccuracy of pre-surgery expectations of pain relief
  100205-4http://loinc.orgAccuracy of pre-surgery expectations to perform activities of daily living
  10020-6http://loinc.orgR' wave amplitude in lead V5
  100206-2http://loinc.orgAccuracy of pre-surgery expectations to perform leisure, recreational, or sports activities
  100207-0http://loinc.orgPost-op total score [Knee Society Score]
  100208-8http://loinc.orgPost-op objective knee indicators score [Knee Society Score]
  100209-6http://loinc.orgPost-op symptoms score [Knee Society Score]
  100210-4http://loinc.orgPost-op patient expectations score [Knee Society Score]
  100211-2http://loinc.orgPost-op functional activities score [Knee Society Score]
  100212-0http://loinc.orgPost-op discretionary knee activities score [Knee Society Score]
  100213-8http://loinc.orgProstate cancer multigene analysis in Blood or Tissue by Molecular genetics method
  10021-4http://loinc.orgR' wave amplitude in lead V6
  100214-6http://loinc.orgDental model prior authorization Document
  100215-3http://loinc.orgEpisode of care medical records Document Transplant surgery
  100216-1http://loinc.orgSurgical synoptic report
  100217-9http://loinc.orgSynoptic report Narrative Surgical oncology
  100218-7http://loinc.orgSurgical oncology of colon cancer synoptic report
  100219-5http://loinc.orgSurgical oncology of melanoma cancer synoptic report
  100220-3http://loinc.orgSurgical oncology of breast cancer synoptic report
  100221-1http://loinc.orgSurgical oncology of thyroid cancer synoptic report
  10022-2http://loinc.orgR' wave duration in lead AVF
  100222-9http://loinc.orgSurgical oncology of pancreas cancer synoptic report
  100223-7http://loinc.orgPhysical findings of Retina Narrative
  100224-5http://loinc.orgCardiac left ventricular segmental wall motion by echo panel
  100225-2http://loinc.orgBone density quantitative ultrasound study
  100226-0http://loinc.orgSmall bowel capsule endoscopy study Document
  100227-8http://loinc.orgColon capsule endoscopy study Document
  100228-6http://loinc.orgUpper gastrointestinal capsule endoscopy study Document
  100229-4http://loinc.orgEndoscopic ultrasound study Document
  10023-0http://loinc.orgR' wave duration in lead AVL
  100230-2http://loinc.orgRoutine prenatal assessment panel
  100231-0http://loinc.orgEndobronchial ultrasound study
  100232-8http://loinc.orgImpacts of Events Scale-Revised panel
  100233-6http://loinc.orgReminders brought back feelings about adverse event
  100234-4http://loinc.orgTrouble staying asleep
  100235-1http://loinc.orgOther things triggered persistent thoughts about adverse event
  100236-9http://loinc.orgFelt irritable AndOr angry
  100237-7http://loinc.orgAvoided getting upset when unintentionally thought about adverse event
  100238-5http://loinc.orgThought about adverse event unintentionally
  100239-3http://loinc.orgFelt as if adverse event did not happen
  100240-1http://loinc.orgAvoided reminders of adverse event
  100241-9http://loinc.orgExperienced mental images of adverse event
  100242-7http://loinc.orgEasily startled
  100243-5http://loinc.orgTried to not think of adverse event
  100244-3http://loinc.orgAware of feelings about adverse event, but did not address them
  100245-0http://loinc.orgFeelings about adverse event were numb
  100246-8http://loinc.orgActed or felt the same as during adverse event
  100247-6http://loinc.orgTrouble falling asleep
  10024-8http://loinc.orgR' wave duration in lead AVR
  100248-4http://loinc.orgWaves of strong feelings about adverse event
  100249-2http://loinc.orgTried to remove adverse event from memory
  1002-5http://loinc.orgDBG Ab [Presence] in Serum or Plasma
  100250-0http://loinc.orgTrouble concentrating
  100251-8http://loinc.orgReminders of adverse event caused physical reactions
  100252-6http://loinc.orgHad dreams about adverse event
  100253-4http://loinc.orgFelt watchful and on-guard
  100254-2http://loinc.orgTried not to talk about adverse event
  10025-5http://loinc.orgR' wave duration in lead I
  100255-9http://loinc.orgTotal score [Impact of Event Scale-Revised]
  100256-7http://loinc.orgFallen in last 6 months
  100257-5http://loinc.orgFeel unsteady when standing or walking
  100258-3http://loinc.orgHistory of fall related injury
  100259-1http://loinc.orgAware of tactile sensations
  100260-9http://loinc.orgEasy to describe thoughts AndOr feelings
  100261-7http://loinc.orgCritical of own thoughts AndOr feelings
  100262-5http://loinc.orgAble to notice distressing thoughts AndOr feelings without having to react
  10026-3http://loinc.orgR' wave duration in lead II
  100263-3http://loinc.orgEasily distracted
  100264-1http://loinc.orgAble to notice thoughts AndOr feelings without being overwhelmed
  100265-8http://loinc.orgAware of dietary intake impact on self
  100266-6http://loinc.orgDifficult to describe thoughts AndOr feelings
  100267-4http://loinc.orgAware of auditory stimuli
  100268-2http://loinc.orgAble to avoid immediate reaction in difficult situations
  100269-0http://loinc.orgDo things without paying attention
  100270-8http://loinc.orgRecover quickly from distressing thoughts AndOr images
  10027-1http://loinc.orgR' wave duration in lead III
  100271-6http://loinc.orgAware of olfactory stimuli
  100272-4http://loinc.orgAware of visual stimuli
  100273-2http://loinc.orgAware of emotions affect on thoughts AndOr behavior
  100274-0http://loinc.orgObserving score [FFMQ]
  100275-7http://loinc.orgDescribing score [FFMQ]
  100276-5http://loinc.orgActing with awareness score [FFMQ]
  100277-3http://loinc.orgNonjudging score [FFMQ]
  100278-1http://loinc.orgNonreactivity score [FFMQ]
  100279-9http://loinc.orgTotal score [FFMQ]
  100280-7http://loinc.orgFive Facet Mindfulness Questionnaire panel [FFMQ]
  100281-5http://loinc.orgD Ab [Units/volume] in Serum or Plasma
  100282-3http://loinc.orgVaccine exemption certificate
  100283-1http://loinc.orgHarris Hip Score panel [Harris Hip Score]
  100284-9http://loinc.orgWalking - functional ability
  100285-6http://loinc.orgComfortable seated position
  100286-4http://loinc.orgAble to board public transportation
  100287-2http://loinc.orgPut on shoes and socks
  100288-0http://loinc.orgAbsence of deformity score [Harris Hip Score]
  10028-9http://loinc.orgR' wave duration in lead V1
  100289-8http://loinc.orgAbsence of hip deformity measurements
  100290-6http://loinc.orgRange of motion score [Harris Hip Score]
  100291-4http://loinc.orgTotal score [Harris Hip Score]
  100292-2http://loinc.orgPre-op patient satisfaction score [Knee Society Score]
  100293-0http://loinc.orgHip Flexion range of motion
  100294-8http://loinc.orgHip Abduction range of motion
  100295-5http://loinc.orgHip Adduction range of motion
  100296-3http://loinc.orgHip External rotation range of motion
  10029-7http://loinc.orgR' wave duration in lead V2
  100297-1http://loinc.orgHip Internal rotation range of motion
  100298-9http://loinc.orgRepetition count
  100299-7http://loinc.orgPost-op patient satisfaction score [Knee Society Score]
  100300-3http://loinc.orgEnd time Unspecified body region
  100301-1http://loinc.orgStart time Unspecified body region
  100302-9http://loinc.orgTime period start and end panel Unspecified body region
  100303-7http://loinc.orgCondition certainty of presence
  100304-5http://loinc.orgFlights climbed [#] Reporting Period
  10030-5http://loinc.orgR' wave duration in lead V3
  100305-2http://loinc.orgIDH1 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
  100306-0http://loinc.orgIDH2 gene exon 4 targeted mutation analysis [Presence] in Blood or Marrow by Molecular genetics method
  100307-8http://loinc.orgBehavioral screening elder mistreatment
  100308-6http://loinc.orgNeed help getting to essential places
  100309-4http://loinc.orgActivity support person
  100310-2http://loinc.orgReliability of support person
  100311-0http://loinc.orgNeed help to make sure there is enough food, medicines or any other things needed in house
  100312-8http://loinc.orgPerson or persons that makes sure there is enough food, medicines or any other things needed in house
  10031-3http://loinc.orgR' wave duration in lead V4
  100313-6http://loinc.orgNeed help with household things such as cook meals, help feed, or provide correct medicines each day
  100314-4http://loinc.orgNeed help with house cleaning or yard work
  100315-1http://loinc.orgNeed help getting out of bed, showered, or dressed
  100316-9http://loinc.orgNeed help to make sure bills get paid
  100317-7http://loinc.orgRelationship of usual support person for daily activities
  100318-5http://loinc.orgHave help with finances AndOr financial decisions
  100319-3http://loinc.orgRelationship of financial support person
  100320-1http://loinc.orgFinancial support person usually asks for permission before making decisions
  10032-1http://loinc.orgR' wave duration in lead V5
  100321-9http://loinc.orgFinancial support person usually makes good decisions about finances
  100322-7http://loinc.orgHave access to paperwork for financial decisions made
  100323-5http://loinc.orgFinancial support person forged signature
  100324-3http://loinc.orgCoercion of financial support person for signing a document in order to get money or possessions
  100325-0http://loinc.orgExperienced theft by support person
  100326-8http://loinc.orgMoney spent or property sold without permission
  100327-6http://loinc.orgStranger forged signature for financial gain
  100328-4http://loinc.orgStranger forced document signature for financial gain
  100329-2http://loinc.orgFeared for safety due to verbal attack
  1003-3http://loinc.orgIndirect antiglobulin test.complement specific reagent [Presence] in Serum or Plasma
  100330-0http://loinc.orgFelt humiliated due to ridicule
  100331-8http://loinc.orgCoerced to do something
  100332-6http://loinc.orgIgnored by close friend or relative for extended period
  100333-4http://loinc.orgPhysically hit or threatened
  100334-2http://loinc.orgBeen physically hurt with some degree of injury
  100335-9http://loinc.orgCoerced sexual activity
  100336-7http://loinc.orgCoerced touching of private body parts of self or others
  100337-5http://loinc.orgCoerced to undress or expose private body area
  100338-3http://loinc.orgPhotographed in any degree of nudity without consent
  10033-9http://loinc.orgR' wave duration in lead V6
  100339-1http://loinc.orgExperienced attempted physical restraint
  100340-9http://loinc.orgRange of motion panel Hip
  100341-7http://loinc.orgRubella virus IgG Ab index [Units/volume] in Serum and CSF
  100342-5http://loinc.orgVolatile Organic Compounds associated with SARS-CoV-2 infection [Presence] in Exhaled gas by Gas chromatography-mass spectrometry
  100343-3http://loinc.orgInfluenza virus B RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
  100344-1http://loinc.orgInfluenza virus A RNA [Presence] in Saliva (oral fluid) by NAA with probe detection
  100345-8http://loinc.orgInfluenza virus A and B and SARS-CoV-2 (COVID-19) RNA panel - Specimen by NAA with probe detection
  100346-6http://loinc.orgClotting time.extrinsic coagulation system activated.platelets inhibited of Blood by Rotational TEG
  10034-7http://loinc.orgS wave amplitude in lead AVF
  100347-4http://loinc.orgClot formation.extrinsic coagulation system activated.platelets inhibited [Time] in Blood by Rotational TEG
  100348-2http://loinc.orgModel for end-stage liver disease sodium score
  100349-0http://loinc.orgUS.doppler Penis vessels W vasodilator IV
  100350-8http://loinc.orgSesamum indicum 1 IgE Ab [Units/volume] in Serum
  100351-6http://loinc.orgPioglitazone [Presence] in Serum or Plasma
  100352-4http://loinc.orgRosiglitazone [Presence] in Serum or Plasma
  100353-2http://loinc.orgNorwalk Community Health Center Screening Tool [NCHC]
  10035-4http://loinc.orgS wave amplitude in lead AVL
  100354-0http://loinc.orgFrequency of participating in multi-modal communication without assistance
  100355-7http://loinc.orgFrequency of participating in spoken language expression communication without assistance
  100356-5http://loinc.orgChlamydia trachomatis and Neisseria gonorrhoeae and Trichomonas vaginalis DNA [Identifier] in Specimen by NAA with probe detection
  100357-3http://loinc.orgNaloxone [Presence] in Cord tissue by Screen method
  100358-1http://loinc.orgPhentermine [Presence] in Cord tissue by Screen method
  100359-9http://loinc.orgGliadin 33 mer peptide [Mass/volume] in Stool by Immunoassay
  100360-7http://loinc.orgBrief Resilience Scale panel [BRS]
  100361-5http://loinc.orgQuickly recover from bad events
  10036-2http://loinc.orgS wave amplitude in lead AVR
  100362-3http://loinc.orgDifficulty making it through stressful events
  100363-1http://loinc.orgEasily recover from a stressful event
  100364-9http://loinc.orgDifficulty recovering from bad events
  100365-6http://loinc.orgEasily recover from difficulties
  100366-4http://loinc.orgLengthy recovery from setbacks
  100367-2http://loinc.orgTotal Score BRS
  100368-0http://loinc.orgAmino Acids Urea Cycle Panel - Serum or Plasma by LC/MS/MS
  100369-8http://loinc.orgNM Thyroid gland Views W Tl-201 IV
  10037-0http://loinc.orgS wave amplitude in lead I
  100370-6http://loinc.orgOrthopoxvirus DNA [Identifier] in Specimen by NAA with probe detection
  100371-4http://loinc.orgTitin Ab [Units/volume] in Serum by Immunoassay
  100372-2http://loinc.orgAbiraterone [Mass/volume] in Serum or Plasma
  100373-0http://loinc.orgEucheuma IgG Ab [Units/volume] in Serum
  100374-8http://loinc.orgAloe vera IgG Ab [Units/volume] in Serum
  100375-5http://loinc.orgAnise IgG Ab [Units/volume] in Serum
  100376-3http://loinc.orgBambusa vulgaris IgG Ab [Units/volume] in Serum
  100377-1http://loinc.orgGoat cheese IgG Ab [Units/volume] in Serum
  100378-9http://loinc.orgSheep cheese IgG Ab [Units/volume] in Serum
  100379-7http://loinc.orgLeeks IgG Ab [Units/volume] in Serum
  100380-5http://loinc.orgRed cabbage IgG Ab [Units/volume] in Serum
  100381-3http://loinc.orgMentha balsamea Wild IgG Ab [Units/volume] in Serum
  100382-1http://loinc.orgFDA package insert REMS addressed risk
  100383-9http://loinc.orgMonkeypox virus DNA [Presence] in Specimen by NAA with probe detection
  100384-7http://loinc.orgRapeseed IgG Ab [Units/volume] in Serum
  100385-4http://loinc.orgCorn salad IgG Ab [Units/volume] in Serum
  100386-2http://loinc.orgRosemary IgG Ab [Units/volume] in Serum
  100387-0http://loinc.orgPoppy Seed IgG Ab [Units/volume] in Serum
  10038-8http://loinc.orgS wave amplitude in lead II
  100388-8http://loinc.orgCocoa IgG Ab [Units/volume] in Serum
  100389-6http://loinc.orgPistachio IgG Ab [Units/volume] in Serum
  100390-4http://loinc.orgSunflower Seed IgG Ab [Units/volume] in Serum
  100391-2http://loinc.orgDates IgG Ab [Units/volume] in Serum
  100392-0http://loinc.orgDuck meat IgG Ab [Units/volume] in Serum
  100393-8http://loinc.orgAllergen Mushroom mix 2 (Xerocomus, Boletus) IgG Ab [Units/volume] in Serum
  100394-6http://loinc.orgAstacoidea IgG Ab [Units/volume] in Serum
  100395-3http://loinc.orgCarob IgG Ab [Units/volume] in Serum
  10039-6http://loinc.orgS wave amplitude in lead III
  100396-1http://loinc.orgBrassica napus IgG Ab [Units/volume] in Serum
  100397-9http://loinc.orgGoat Meat IgG Ab [Units/volume] in Serum
  100398-7http://loinc.orgGoose meat IgG Ab [Units/volume] in Serum
  100399-5http://loinc.orgOstrich meat IgG Ab [Units/volume] in Serum
  100400-1http://loinc.orgQuail meat IgG Ab [Units/volume] in Serum
  100401-9http://loinc.orgRabbit meat IgG Ab [Units/volume] in Serum
  100402-7http://loinc.orgVenison meat IgG Ab [Units/volume] in Serum
  100403-5http://loinc.orgGuineafowl IgG Ab [Units/volume] in Serum
  10040-4http://loinc.orgS wave amplitude in lead V1
  100404-3http://loinc.orgHorse meat IgG Ab [Units/volume] in Serum
  100405-0http://loinc.orgKefir IgG Ab [Units/volume] in Serum
  100406-8http://loinc.orgButter IgG Ab [Units/volume] in Serum
  100407-6http://loinc.orgCamembert cheese IgG Ab [Units/volume] in Serum
  100408-4http://loinc.orgEmmental cheese IgG Ab [Units/volume] in Serum
  100409-2http://loinc.orgProcessed cheese IgG Ab [Units/volume] in Serum
  1004-1http://loinc.orgDirect antiglobulin test.complement specific reagent [Presence] on Red Blood Cells
  100410-0http://loinc.orgCurd cheese IgG Ab [Units/volume] in Serum
  100411-8http://loinc.orgSugar Beet IgG Ab [Units/volume] in Serum
  10041-2http://loinc.orgS wave amplitude in lead V2
  100412-6http://loinc.orgChinese cabbage IgG Ab [Units/volume] in Serum
  100413-4http://loinc.orgFennel Fresh IgG Ab [Units/volume] in Serum
  100414-2http://loinc.orgGourd IgG Ab [Units/volume] in Serum
  100415-9http://loinc.orgKale IgG Ab [Units/volume] in Serum
  100416-7http://loinc.orgSavoy cabbage IgG Ab [Units/volume] in Serum
  100417-5http://loinc.orgVitis sp leaf IgG Ab [Units/volume] in Serum
  100418-3http://loinc.orgLiquorice IgG Ab [Units/volume] in Serum
  100419-1http://loinc.orgSnow pea IgG Ab [Units/volume] in Serum
  10042-0http://loinc.orgS wave amplitude in lead V3
  100420-9http://loinc.orgFava bean IgG Ab [Units/volume] in Serum
  100421-7http://loinc.orgChick Pea IgG Ab [Units/volume] in Serum
  100422-5http://loinc.orgChicory IgG Ab [Units/volume] in Serum
  100423-3http://loinc.orgAllergy Mushroom Mix 1 (Button + oyster + Shiitaki + chanterelle mushroom) IgG Ab [Units/volume] in Serum
  100424-1http://loinc.org8(9)-Cholestenol [Mass/volume] in Serum or Plasma
  100425-8http://loinc.orgDiHydro T-Mas [Mass/volume] in Serum or Plasma
  100426-6http://loinc.orgSqualene [Mass/volume] in Serum or Plasma
  100427-4http://loinc.orgStigmasterol [Mass/volume] in Serum or Plasma
  100428-2http://loinc.orgCarnitine free and total and acylcarnitine panel - Urine
  100429-0http://loinc.orgLRBA deficiency panel - Blood
  100430-8http://loinc.orgCells.LRBA+/100 Cells.CD3+CD14-CD45+ in Blood by Flow cytometry (FC)
  100431-6http://loinc.orgCells.CD3+CD14-CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
  100432-4http://loinc.orgCells.LRBA+/100 Cells.CD3-CD14-CD19+CD45+ in Blood by Flow cytometry (FC)
  100433-2http://loinc.orgCells.CD3-CD14-CD19+CD45+.LRBA mean fluorescence intensity in Blood by Flow cytometry (FC)
  100434-0http://loinc.orgOrthopoxvirus.non-variola DNA [Presence] in Specimen by NAA with probe detection
  100435-7http://loinc.orgGlial fibrillary acidic protein [Mass/volume] in Serum by Immunoassay
  100436-5http://loinc.orgUbiquitin carboxyl-terminal hydrolase-L1 [Mass/volume] in Serum by Immunoassay
  100437-3http://loinc.orgNorsufentanil [Mass/volume] in Urine by Confirmatory method
  10043-8http://loinc.orgS wave amplitude in lead V4
  100438-1http://loinc.orgAdolescent medicine Outpatient Progress note
  100439-9http://loinc.orgAllergy and Immunology Outpatient Progress note
  100440-7http://loinc.orgAllergy Outpatient Progress note
  100441-5http://loinc.orgAttending Outpatient Progress note
  100442-3http://loinc.orgAudiology Outpatient Progress note
  100443-1http://loinc.orgBariatric surgery Outpatient Progress note
  100444-9http://loinc.orgBlood banking and transfusion medicine Outpatient Progress note
  100445-6http://loinc.orgBone Marrow Transplant Outpatient Progress note
  10044-6http://loinc.orgS wave amplitude in lead V5
  100446-4http://loinc.orgBreastfeeding Outpatient Progress note
  100447-2http://loinc.orgBurn management Outpatient Progress note
  100448-0http://loinc.orgCardiac surgery Outpatient Progress note
  100449-8http://loinc.orgCardiopulmonary Outpatient Progress note
  100450-6http://loinc.orgChild and adolescent psychiatry Outpatient Progress note
  100451-4http://loinc.orgChiropractic medicine Outpatient Progress note
  100452-2http://loinc.orgClinical cardiac electrophysiology Outpatient Progress note
  10045-3http://loinc.orgS wave amplitude in lead V6
  100453-0http://loinc.orgClinical genetics Outpatient Progress note
  100454-8http://loinc.orgClinical neurophysiology Outpatient Progress note
  100455-5http://loinc.orgClinical pathology Outpatient Progress note
  100456-3http://loinc.orgColon and rectal surgery Outpatient Progress note
  100457-1http://loinc.orgConsultant Outpatient Progress note
  100458-9http://loinc.orgOutpatient COVID-19 Intubation Progress note
  100459-7http://loinc.orgOutpatient COVID-19 Progress note
  100460-5http://loinc.orgDermatology Outpatient Progress note
  10046-1http://loinc.orgS wave duration in lead AVF
  100461-3http://loinc.orgDevelopmental-behavioral pediatrics Outpatient Progress note
  100462-1http://loinc.orgDialysis and Therapeutic apheresis Outpatient Progress note
  100463-9http://loinc.orgEating disorders Outpatient Progress note
  100464-7http://loinc.orgEndocrinology Outpatient Progress note
  100465-4http://loinc.orgFamily medicine Outpatient Progress note
  100466-2http://loinc.orgGastroenterology Outpatient Progress note
  100467-0http://loinc.orgGeriatric medicine Outpatient Progress note
  100468-8http://loinc.orgGynecologic oncology Outpatient Progress note
  100469-6http://loinc.orgGynecology Outpatient Progress note
  100470-4http://loinc.orgHealthcare navigator Outpatient Progress note
  100471-2http://loinc.orgHeart failure Outpatient Progress note
  100472-0http://loinc.orgHeart failure+Transplant cardiology Outpatient Progress note
  100473-8http://loinc.orgHematology Outpatient Progress note
  100474-6http://loinc.orgHematology+Medical oncology Outpatient Progress note
  100475-3http://loinc.orgHepatology Outpatient Progress note
  100476-1http://loinc.orgImmunology Outpatient Progress note
  100477-9http://loinc.orgInfectious disease Outpatient Progress note
  100478-7http://loinc.orgInternal medicine Outpatient Progress note
  10047-9http://loinc.orgS wave duration in lead AVL
  100479-5http://loinc.orgInterventional cardiology Outpatient Progress note
  100480-3http://loinc.orgInterventional radiology Outpatient Progress note
  100481-1http://loinc.orgOutpatient Mechanical circulatory support Progress note
  100482-9http://loinc.orgMedical Aid in Dying Outpatient Progress note
  100483-7http://loinc.orgMental health Outpatient Progress note
  100484-5http://loinc.orgMulti-specialty program Outpatient Progress note
  100485-2http://loinc.orgNeonatal perinatal medicine Outpatient Progress note
  100486-0http://loinc.orgNephrology Outpatient Progress note
  10048-7http://loinc.orgS wave duration in lead AVR
  100487-8http://loinc.orgNeurological surgery Outpatient Progress note
  100488-6http://loinc.orgNeurology Outpatient Progress note
  100489-4http://loinc.orgNeurology with special qualifications in child neurology Outpatient Progress note
  100490-2http://loinc.orgNurse practitioner Outpatient Progress note
  100491-0http://loinc.orgNurse Outpatient Progress note
  100492-8http://loinc.orgNutrition and dietetics Outpatient Progress note
  100493-6http://loinc.orgObstetrics and Gynecology Outpatient Progress note
  100494-4http://loinc.orgObstetrics Outpatient Progress note
  10049-5http://loinc.orgS wave duration in lead I
  100495-1http://loinc.orgOccupational therapy Outpatient Progress note
  100496-9http://loinc.orgOncology Outpatient Progress note
  100497-7http://loinc.orgOphthalmology Outpatient Progress note
  100498-5http://loinc.orgOptometry Outpatient Progress note
  100499-3http://loinc.orgOral and Maxillofacial Surgery Outpatient Progress note
  100500-8http://loinc.orgOrthopaedic surgery Outpatient Progress note
  100501-6http://loinc.orgOrthotics prosthetics Outpatient Progress note
  100502-4http://loinc.orgOtolaryngology Outpatient Progress note
  10050-3http://loinc.orgS wave duration in lead II
  100503-2http://loinc.orgPain medicine Outpatient Progress note
  100504-0http://loinc.orgPalliative care Outpatient Progress note
  100505-7http://loinc.orgPediatric cardiology Outpatient Progress note
  100506-5http://loinc.orgPediatric dermatology Outpatient Progress note
  100507-3http://loinc.orgPediatric endocrinology Outpatient Progress note
  100508-1http://loinc.orgPediatric gastroenterology Outpatient Progress note
  100509-9http://loinc.orgPediatric hematology-oncology Outpatient Progress note
  100510-7http://loinc.orgPediatric infectious diseases Outpatient Progress note
  10051-1http://loinc.orgS wave duration in lead III
  100511-5http://loinc.orgPediatric otolaryngology Outpatient Progress note
  100512-3http://loinc.orgPediatric pulmonology Outpatient Progress note
  100513-1http://loinc.orgPediatric rheumatology Outpatient Progress note
  100514-9http://loinc.orgPediatric surgery Outpatient Progress note
  100515-6http://loinc.orgPediatric transplant hepatology Outpatient Progress note
  100516-4http://loinc.orgPediatric urology Outpatient Progress note
  100517-2http://loinc.orgPharmacogenomics Outpatient Progress note
  100518-0http://loinc.orgPhysical medicine and rehab Outpatient Progress note
  100519-8http://loinc.orgPhysical therapy Outpatient Progress note
  100520-6http://loinc.orgPlastic surgery Outpatient Progress note
  100521-4http://loinc.orgPodiatry Outpatient Progress note
  100522-2http://loinc.orgPsychiatry Hospital Progress note
  100523-0http://loinc.orgPsychology Outpatient Progress note
  100524-8http://loinc.orgPulmonary Outpatient Progress note
  100525-5http://loinc.orgRadiation oncology Outpatient Progress note
  100526-3http://loinc.orgRadiology Outpatient Progress note
  100527-1http://loinc.orgRecreational therapy Outpatient Progress note
  100528-9http://loinc.orgReproductive endocrinology and infertility Outpatient Progress note
  10052-9http://loinc.orgS wave duration in lead V1
  100529-7http://loinc.orgResearch Outpatient Progress note
  100530-5http://loinc.orgRheumatology Outpatient Progress note
  100531-3http://loinc.orgSleep medicine Outpatient Progress note
  100532-1http://loinc.orgSocial worker Outpatient Progress note
  100533-9http://loinc.orgSolid Organ Transplant Outpatient Progress note
  100534-7http://loinc.orgSpeech-language pathology Outpatient Progress note
  100535-4http://loinc.orgSpinal surgery Outpatient Progress note
  100536-2http://loinc.orgSports medicine Outpatient Progress note
  10053-7http://loinc.orgS wave duration in lead V2
  100537-0http://loinc.orgSurgery of the hand Outpatient Progress note
  100538-8http://loinc.orgTelehealth+Outpatient Progress note
  100539-6http://loinc.orgThromboembolism Outpatient Progress note
  100540-4http://loinc.orgTransplant surgery Outpatient Progress note
  100541-2http://loinc.orgTrauma Outpatient Progress note
  100542-0http://loinc.orgUrology Outpatient Progress note
  100543-8http://loinc.orgVascular neurology Outpatient Progress note
  100544-6http://loinc.orgVascular surgery Outpatient Progress note
  10054-5http://loinc.orgS wave duration in lead V3
  100545-3http://loinc.orgWound care management Outpatient Progress note
  100546-1http://loinc.orgWound, Ostomy, and Continence Care Outpatient Progress note
  100547-9http://loinc.orgAdolescent medicine Hospital Progress note
  100548-7http://loinc.orgAllergy and Immunology Hospital Progress note
  100549-5http://loinc.orgAllergy Hospital Progress note
  100550-3http://loinc.orgAttending Hospital Progress note
  100551-1http://loinc.orgAudiology Hospital Progress note
  10055-2http://loinc.orgS wave duration in lead V4
  100552-9http://loinc.orgBariatric surgery Hospital Progress note
  100553-7http://loinc.orgBlood banking and transfusion medicine Hospital Progress note
  100554-5http://loinc.orgBone Marrow Transplant Hospital Progress note
  100555-2http://loinc.orgBreastfeeding Hospital Progress note
  100556-0http://loinc.orgBurn management Hospital Progress note
  100557-8http://loinc.orgCardiac surgery Hospital Progress note
  100558-6http://loinc.orgCardiopulmonary Hospital Progress note
  100559-4http://loinc.orgChild and adolescent psychiatry Hospital Progress note
  10056-0http://loinc.orgS wave duration in lead V5
  100560-2http://loinc.orgClinical cardiac electrophysiology Hospital Progress note
  100561-0http://loinc.orgClinical genetics Hospital Progress note
  100562-8http://loinc.orgClinical neurophysiology Hospital Progress note
  100563-6http://loinc.orgClinical pathology Hospital Progress note
  100564-4http://loinc.orgColon and rectal surgery Hospital Progress note
  100565-1http://loinc.orgConsultant Hospital Progress note
  100566-9http://loinc.orgDentistry Hospital Progress note
  100567-7http://loinc.orgDermatology Hospital Progress note
  100568-5http://loinc.orgDevelopmental-behavioral pediatrics Hospital Progress note
  100569-3http://loinc.orgDialysis and Therapeutic apheresis Hospital Progress note
  100570-1http://loinc.orgEating disorders Hospital Progress note
  100571-9http://loinc.orgEndocrinology Hospital Progress note
  100572-7http://loinc.orgFamily medicine Hospital Progress note
  100573-5http://loinc.orgGastroenterology Hospital Progress note
  100574-3http://loinc.orgGeneral medicine Hospital Progress note
  100575-0http://loinc.orgGeriatric medicine Hospital Progress note
  100576-8http://loinc.orgGynecologic oncology Hospital Progress note
  100577-6http://loinc.orgGynecology Hospital Progress note
  10057-8http://loinc.orgS wave duration in lead V6
  100578-4http://loinc.orgHealthcare navigator Hospital Progress note
  100579-2http://loinc.orgHeart failure Hospital Progress note
  1005-8http://loinc.orgIndirect antiglobulin test.IgG specific reagent [Presence] in Serum or Plasma
  100580-0http://loinc.orgHeart failure+Transplant cardiology Hospital Progress note
  100581-8http://loinc.orgHematology Hospital Progress note
  100582-6http://loinc.orgHematology+Medical oncology Hospital Progress note
  100583-4http://loinc.orgHepatology Hospital Progress note
  100584-2http://loinc.orgImmunology Hospital Progress note
  100585-9http://loinc.orgInfectious disease Hospital Progress note
  10058-6http://loinc.orgS' wave amplitude in lead AVF
  100586-7http://loinc.orgInternal medicine Hospital Progress note
  100587-5http://loinc.orgInterventional cardiology Hospital Progress note
  100588-3http://loinc.orgInterventional radiology Hospital Progress note
  100589-1http://loinc.orgHospital Mechanical circulatory support Progress note
  100590-9http://loinc.orgMedical Aid in Dying Hospital Progress note
  100591-7http://loinc.orgMental health Hospital Progress note
  100592-5http://loinc.orgMulti-specialty program Hospital Progress note
  100593-3http://loinc.orgNeonatal perinatal medicine Hospital Progress note
  10059-4http://loinc.orgS' wave amplitude in lead AVL
  100594-1http://loinc.orgNephrology Hospital Progress note
  100595-8http://loinc.orgNeurological surgery Hospital Progress note
  100596-6http://loinc.orgNeurology Hospital Progress note
  100597-4http://loinc.orgNeurology with special qualifications in child neurology Hospital Progress note
  100598-2http://loinc.orgNurse practitioner Hospital Progress note
  100599-0http://loinc.orgNurse Hospital Progress note
  100600-6http://loinc.orgNutrition and dietetics Hospital Progress note
  100601-4http://loinc.orgObstetrics and Gynecology Hospital Progress note
  10060-2http://loinc.orgS' wave amplitude in lead AVR
  100602-2http://loinc.orgObstetrics Hospital Progress note
  100603-0http://loinc.orgOccupational therapy Hospital Progress note
  100604-8http://loinc.orgOncology Hospital Progress note
  100605-5http://loinc.orgOphthalmology Hospital Progress note
  100606-3http://loinc.orgOral and Maxillofacial Surgery Hospital Progress note
  100607-1http://loinc.orgOrthopaedic surgery Hospital Progress note
  100608-9http://loinc.orgOrthotics prosthetics Hospital Progress note
  100609-7http://loinc.orgOtolaryngology Hospital Progress note
  10061-0http://loinc.orgS' wave amplitude in lead I
  100610-5http://loinc.orgPain medicine Hospital Progress note
  100611-3http://loinc.orgPalliative care Hospital Progress note
  100612-1http://loinc.orgPastoral care Hospital Progress note
  100613-9http://loinc.orgPediatric cardiology Hospital Progress note
  100614-7http://loinc.orgPediatric dermatology Hospital Progress note
  100615-4http://loinc.orgPediatric endocrinology Hospital Progress note
  100616-2http://loinc.orgPediatric gastroenterology Hospital Progress note
  100617-0http://loinc.orgPediatric hematology-oncology Hospital Progress note
  100618-8http://loinc.orgPediatric infectious diseases Hospital Progress note
  100619-6http://loinc.orgPediatric otolaryngology Hospital Progress note
  100620-4http://loinc.orgPediatric pulmonology Hospital Progress note
  100621-2http://loinc.orgPediatric rheumatology Hospital Progress note
  100622-0http://loinc.orgPediatric surgery Hospital Progress note
  100623-8http://loinc.orgPediatric transplant hepatology Hospital Progress note
  100624-6http://loinc.orgPharmacogenomics Hospital Progress note
  100625-3http://loinc.orgPharmacology Hospital Progress note
  100626-1http://loinc.orgPhysical medicine and rehab Hospital Progress note
  100627-9http://loinc.orgPhysical therapy Hospital Progress note
  10062-8http://loinc.orgS' wave amplitude in lead II
  100628-7http://loinc.orgPlastic surgery Hospital Progress note
  100629-5http://loinc.orgPodiatry Hospital Progress note
  100630-3http://loinc.orgPsychology Hospital Progress note
  100631-1http://loinc.orgRadiation oncology Hospital Progress note
  100632-9http://loinc.orgRadiology Hospital Progress note
  100633-7http://loinc.orgRapid response team Hospital Progress note
  100634-5http://loinc.orgRecreational therapy Hospital Progress note
  100635-2http://loinc.orgReproductive endocrinology and infertility Hospital Progress note
  10063-6http://loinc.orgS' wave amplitude in lead III
  100636-0http://loinc.orgResearch Hospital Progress note
  100637-8http://loinc.orgRheumatology Hospital Progress note
  100638-6http://loinc.orgSleep medicine Hospital Progress note
  100639-4http://loinc.orgSocial worker Hospital Progress note
  100640-2http://loinc.orgSolid Organ Transplant Hospital Progress note
  100641-0http://loinc.orgSpeech-language pathology Hospital Progress note
  100642-8http://loinc.orgSpinal surgery Hospital Progress note
  100643-6http://loinc.orgSurgery of the hand Hospital Progress note
  10064-4http://loinc.orgS' wave amplitude in lead V1
  100644-4http://loinc.orgThromboembolism Hospital Progress note
  100645-1http://loinc.orgTrauma Hospital Progress note
  100646-9http://loinc.orgUrology Hospital Progress note
  100647-7http://loinc.orgVascular neurology Hospital Progress note
  100648-5http://loinc.orgVascular surgery Hospital Progress note
  100649-3http://loinc.orgWound care management Hospital Progress note
  100650-1http://loinc.orgWound, Ostomy, and Continence Care Hospital Progress note
  10065-1http://loinc.orgS' wave amplitude in lead V2
  100651-9http://loinc.orgHospital COVID-19 Intubation Progress note
  100652-7http://loinc.orgPure tone bone conduction threshold audiometry panel
  100653-5http://loinc.orgPure tone air conduction threshold audiometry panel
  100654-3http://loinc.orgPyruvate kinase M2 [Presence] in Stool
  100655-0http://loinc.orgXR Sella turcica Lateral
  100656-8http://loinc.orgMaternal and fetal medicine Outpatient Progress note
  100657-6http://loinc.orgMaternal and fetal medicine Telephone encounter+Hospital Progress note
  100658-4http://loinc.orgHospital COVID-19 Progress note
  100659-2http://loinc.orgMaternal and fetal medicine Hospital Progress note
  1006-6http://loinc.orgDirect antiglobulin test.IgG specific reagent [Interpretation] on Red Blood Cells
  100660-0http://loinc.orgMaternal and fetal medicine Telephone encounter+Outpatient Progress note
  100661-8http://loinc.orgPsychiatry Outpatient Progress note
  100662-6http://loinc.orgCortisol free and total panel - Serum or Plasma
  100663-4http://loinc.orgTPMT gene c.460G>A and c.719A>G [Presence] in Blood by Molecular genetics method
  100664-2http://loinc.orgNUDT15 gene c.50_55dup and c.415C>T [Presence] in Blood by Molecular genetics method
  100665-9http://loinc.orgNUDT15 gene c.415C>T [Presence] in Blood by Molecular genetics method
  100666-7http://loinc.orgNUDT15 gene c.416G>A [Presence] in Blood by Molecular genetics method
  100667-5http://loinc.orgNUDT15 gene c.52G>A [Presence] in Blood by Molecular genetics method
  100668-3http://loinc.orgNUDT15 gene c.50_55dup [Presence] in Blood by Molecular genetics method
  10066-9http://loinc.orgS' wave amplitude in lead V3
  100669-1http://loinc.orgNUDT15 gene c.50_55del [Presence] in Blood by Molecular genetics method
  100670-9http://loinc.orgRHD gene allele [Identifier] in Plasma cell-free DNA Nominal--fetus
  100671-7http://loinc.orgAspergillus sp DNA [Presence] in Blood by NAA with probe detection
  100672-5http://loinc.orgAspergillus fumigatus DNA [Presence] in Blood by NAA with probe detection
  100673-3http://loinc.orgAspergillus terreus DNA [Presence] in Blood by NAA with probe detection
  100674-1http://loinc.orgBK virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100675-8http://loinc.orgCytomegalovirus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
  100676-6http://loinc.orgCytomegalovirus DNA [log units/volume] (viral load) in Blood by NAA with probe detection
  10067-7http://loinc.orgS' wave amplitude in lead V4
  100677-4http://loinc.orgEpstein Barr virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100678-2http://loinc.orgEpstein Barr virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100679-0http://loinc.orgHerpes virus 6 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100680-8http://loinc.orgHerpes virus 6 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100681-6http://loinc.orgHerpes virus 7 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100682-4http://loinc.orgHerpes virus 7 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100683-2http://loinc.orgHerpes virus 8 DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100684-0http://loinc.orgHerpes virus 8 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  10068-5http://loinc.orgS' wave amplitude in lead V5
  100685-7http://loinc.orgJC virus DNA [Log #/volume] (viral load) in Serum or Plasma by NAA with probe detection
  100686-5http://loinc.orgJC virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
  100687-3http://loinc.orgJC virus DNA [Log #/volume] (viral load) in Urine by NAA with probe detection
  100688-1http://loinc.orgParvovirus B19 DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100689-9http://loinc.orgToxoplasma gondii DNA [Log #/volume] in Serum or Plasma by NAA with probe detection
  100690-7http://loinc.orgToxoplasma gondii DNA [Log #/volume] in Cerebral spinal fluid by NAA with probe detection
  100691-5http://loinc.orgVaricella zoster virus DNA [Log #/volume] (viral load) in Blood by NAA with probe detection
  100692-3http://loinc.orgVaricella zoster virus DNA [Log #/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection
  10069-3http://loinc.orgS' wave amplitude in lead V6
  100693-1http://loinc.orgPneumocystis jiroveci DNA [Log #/volume] in Respiratory system specimen by NAA with probe detection
  100694-9http://loinc.orgSMN1 gene silent carrier analysis [Presence] in Blood or Tissue by Molecular genetics method
  100695-6http://loinc.orgGenetic disease analysis overall carrier interpretation in Blood or Tissue by Molecular genetics method Narrative
  100696-4http://loinc.orgCTNS related multigene analysis [Identifier] in Bodyfluid and Serum or Plasma by Molecular genetics method Nominal
  100697-2http://loinc.orgInterventional radiology Outpatient Note
  100698-0http://loinc.orgSocial Determinants of Health screening report Document
  100699-8http://loinc.orgRifabutin+Ethambutol [Susceptibility]
  100700-4http://loinc.orgTrichomonas vaginalis DNA [Presence] in Urethra by NAA with probe detection
  10070-1http://loinc.orgS' wave duration in lead AVF
  100701-2http://loinc.orgTrichomonas vaginalis rRNA [Presence] in Urethra by NAA with probe detection
  100702-0http://loinc.orgMycoplasma genitalium rRNA [Presence] in Urethra by NAA with probe detection
  100703-8http://loinc.orgMycoplasma genitalium rRNA [Presence] in Urine by NAA with probe detection
  100704-6http://loinc.orgMycoplasma genitalium rRNA [Presence] in Cervix by NAA with probe detection
  100705-3http://loinc.orgMycoplasma genitalium rRNA [Presence] in Anorectal by NAA with probe detection
  100706-1http://loinc.orgMycoplasma genitalium rRNA [Presence] in Specimen by NAA with probe detection
  100707-9http://loinc.orgPolymorphonuclear cells [#/volume] in Peritoneal dialysis fluid by Automated count
  100708-7http://loinc.orgPlasma cells/100 leukocytes in Synovial fluid
  100709-5http://loinc.orgHepatocellular carcinoma risk [Score] by GAAD
  100710-3http://loinc.orgChlamydia trachomatis and Neisseria gonorrhoeae rRNA panel - Throat by NAA with probe detection
  100711-1http://loinc.orgBorrelia burgdorferi.VlsE1+pepC10 Ab [Units/volume] in Serum by Immunoassay
  100712-9http://loinc.orgBrexpiprazole [Mass/volume] in Serum or Plasma
  100713-7http://loinc.orgCariprazine [Mass/volume] in Serum or Plasma
  100714-5http://loinc.orgGuanfacine [Mass/volume] in Serum or Plasma
  100715-2http://loinc.orgProthipendyl [Mass/volume] in Serum or Plasma
  100716-0http://loinc.orgProstate specific Ag [Mass/volume] in DBS
  100717-8http://loinc.orgFCGR3A gene.p.Phe176Val [Presence] in Blood or Tissue by Molecular genetics method
  100718-6http://loinc.orgUndersea and hyperbaric medicine Discharge summary
  10071-9http://loinc.orgS' wave duration in lead AVL
  100719-4http://loinc.orgSurgical oncology Discharge summary
  100720-2http://loinc.orgReproductive endocrinology and infertility Discharge summary
  100721-0http://loinc.orgCommunity health care Discharge summary
  100722-8http://loinc.orgIntegrative medicine Discharge summary
  100723-6http://loinc.orgSports medicine Discharge summary
  100724-4http://loinc.orgDiabetology Discharge summary
  100725-1http://loinc.orgOptometry Discharge summary
  100726-9http://loinc.orgPodiatry Discharge summary
  10072-7http://loinc.orgS' wave duration in lead AVR
  100727-7http://loinc.orgChiropractic medicine Discharge summary
  100728-5http://loinc.orgCardiac surgery Discharge summary
  100729-3http://loinc.orgBreastfeeding Discharge summary
  100730-1http://loinc.orgTransplant surgery Discharge summary
  100731-9http://loinc.orgUrgent care center Discharge summary
  100732-7http://loinc.orgCholesterol.in lipoprotein (little a) and Cholesterol.in LDL panel - Serum
  100733-5http://loinc.orgCholesterol in LDL [Mass/volume] in Serum by calculation --corrected for Cholesterol.in lipoprotein (little a)
  100734-3http://loinc.orgtraMADol and Metabolites Panel - Urine by Confirmatory method
  10073-5http://loinc.orgS' wave duration in lead I
  100735-0http://loinc.orgMannose-6-phosphate isomerase and phosphomannomutase 1 panel - Leukocytes
  100736-8http://loinc.orgAcylcarnitine Analysis Post Mortem in Specimen Document
  100737-6http://loinc.orgAlkaline phosphatase.macromolecular [Presence] in Serum or Plasma
  100738-4http://loinc.orgAlanine aminotransferase.macromolecular [Presence] in Serum or Plasma
  100739-2http://loinc.orgAspartate aminotransferase.macromolecular [Presence] in Serum or Plasma
  1007-4http://loinc.orgDirect antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
  100740-0http://loinc.orgAmylase.macromolecular [Presence] in Serum or Plasma
  100741-8http://loinc.orgGamma glutamyl transferase.macromolecular [Presence] in Serum or Plasma
  100742-6http://loinc.orgLactate dehydrogenase.macromolecular [Presence] in Serum or Plasma
  10074-3http://loinc.orgS' wave duration in lead II
  100743-4http://loinc.orgLipase.macromolecular [Presence] in Serum or Plasma
  100744-2http://loinc.orgAlpha-1-acid glycoprotein [Mass/volume] in Serum or Plasma by Electrophoresis
  100745-9http://loinc.orgChloride [Moles/volume] in Mixed venous blood
  100746-7http://loinc.orgGlucose [Moles/volume] in Mixed venous blood
  100747-5http://loinc.orgLegionella serogroup panel - Specimen
  100748-3http://loinc.orgLegionella spp [Presence] in Specimen by NAA with probe detection
  100749-1http://loinc.orgLegionella pneumophila serogroup 1 [Presence] in Specimen by NAA with probe detection
  10075-0http://loinc.orgS' wave duration in lead III
  100750-9http://loinc.orgLegionella pneumophila non-serogroup 1 [Presence] in Specimen by NAA with probe detection
  100751-7http://loinc.orgGalactose-alpha-1,3-galactose (Alpha-Gal) panel - Serum or Plasma
  100752-5http://loinc.orgExacerbating factors - Reported
  100753-3http://loinc.orgAlleviating factors - Reported
  100754-1http://loinc.orgPlatelet disorders multigene analysis in Blood or Tissue by Sequencing
  100755-8http://loinc.orgOligoclonal bands [#] in Serum or Plasma by Isoelectric focusing
  100756-6http://loinc.orgOligoclonal bands [Interpretation] in Cerebral spinal fluid by Isoelectric focusing
  100757-4http://loinc.orgProtein fractions.oligoclonal bands panel - Serum and CSF by Isoelectric focusing
  100758-2http://loinc.orgEstimated lung age by based on clinical data
  100759-0http://loinc.orgInspiratory reserve [Volume] Respiratory system by Spirometry
  100760-8http://loinc.orgXR Radius and Ulna - left Single view
  100761-6http://loinc.orgPALB2 gene targeted mutation analysis in Blood or Tissue by Molecular genetics method
  100762-4http://loinc.orgHBA2 gene.c.377T>C [Presence] in Blood by Molecular genetics method
  100763-2http://loinc.orgMycobacterium sp comparative reaction interpretation Narrative
  100764-0http://loinc.orgMycobacterium bovis reaction wheal [Diameter] Qualitative --3 days post dose mammalian tuberculin intradermal
  100765-7http://loinc.orgHomocysteine and methylmalonate and methylcitrate panel - DBS
  100766-5http://loinc.orgCenter for Epidemiologic Studies Depression Scale panel [CES-D]
  100767-3http://loinc.orgBothered by things that are not usually bothersome
  10076-8http://loinc.orgS' wave duration in lead V1
  100768-1http://loinc.orgPoor appetite
  100769-9http://loinc.orgUnhappy even with help from my family or friends
  100770-7http://loinc.orgFeeling just as good as others
  100771-5http://loinc.orgTrouble focusing
  100772-3http://loinc.orgFeeling depressed
  100773-1http://loinc.orgFeeling everything is too much of an effort
  100774-9http://loinc.orgFeeling hopeful about the future
  100775-6http://loinc.orgFeeling life had been a failure
  10077-6http://loinc.orgS' wave duration in lead V2
  100776-4http://loinc.orgFeeling fearful
  100777-2http://loinc.orgRestless sleep
  100778-0http://loinc.orgFeeling happy
  100779-8http://loinc.orgQuieter than usual
  100780-6http://loinc.orgFeeling lonely
  100781-4http://loinc.orgPeople were unfriendly
  100782-2http://loinc.orgEnjoying life
  100783-0http://loinc.orgCrying spells
  10078-4http://loinc.orgS' wave duration in lead V3
  100784-8http://loinc.orgFeeling sad
  100785-5http://loinc.orgFeeling people dislike me
  100786-3http://loinc.orgLack of energy
  100787-1http://loinc.orgTotal Score CES-D
  100788-9http://loinc.orgStemphylium botryosum IgG4 Ab [Mass/volume] in Serum
  100789-7http://loinc.orgRhizopus nigricans IgG4 Ab [Mass/volume] in Serum
  100790-5http://loinc.orgLepidoglyphus destructor IgG Ab [Mass/volume] in Serum
  100791-3http://loinc.orgHamster epithelium IgG Ab [Mass/volume] in Serum
  10079-2http://loinc.orgS' wave duration in lead V4
  100792-1http://loinc.orgForsythia IgE Ab [Units/volume] in Serum
  100793-9http://loinc.orgTestosterone [Mass/volume] in Body fluid
  100794-7http://loinc.orgFollitropin [Units/volume] in Body fluid
  100795-4http://loinc.orgS100 calcium binding protein B [Mass/volume] in Body fluid
  100796-2http://loinc.orgThyroglobulin [Mass/volume] in Body fluid
  100797-0http://loinc.orgTestosterone Free [Mass/volume] in Serum --1st specimen post XXX challenge
  100798-8http://loinc.orgTestosterone Free [Mass/volume] in Serum --2nd specimen post XXX challenge
  100799-6http://loinc.org21-Deoxycortisol [Mass/volume] in Serum --1st specimen post XXX challenge
  100-8http://loinc.orgCefoperazone [Susceptibility] by Minimum inhibitory concentration (MIC)
  10080-0http://loinc.orgS' wave duration in lead V5
  100800-2http://loinc.org21-Deoxycortisol [Mass/volume] in Serum --2nd specimen post XXX challenge
  100801-0http://loinc.org21-Deoxycortisol [Mass/volume] in Serum --3rd specimen post XXX challenge
  100802-8http://loinc.org21-Deoxycortisol [Mass/volume] in Serum --4th specimen post XXX challenge
  100803-6http://loinc.org21-Deoxycortisol [Mass/volume] in Serum --5th specimen post XXX challenge
  100804-4http://loinc.orgVasopressin [Moles/volume] in Plasma --1st specimen post XXX challenge
  100805-1http://loinc.orgVasopressin [Moles/volume] in Plasma --2nd specimen post XXX challenge
  100806-9http://loinc.orgVasopressin [Moles/volume] in Plasma --3rd specimen post XXX challenge
  100807-7http://loinc.orgVasopressin [Moles/volume] in Plasma --4th specimen post XXX challenge
  100808-5http://loinc.orgVasopressin [Moles/volume] in Plasma --5th specimen post XXX challenge
  100809-3http://loinc.orgVasopressin [Moles/volume] in Plasma --6th specimen post XXX challenge
  100810-1http://loinc.orgVasopressin [Moles/volume] in Plasma --7th specimen post XXX challenge
  100811-9http://loinc.orgVasopressin [Moles/volume] in Plasma --8th specimen post XXX challenge
  100812-7http://loinc.orgVasopressin [Moles/volume] in Plasma --9th specimen post XXX challenge
  100813-5http://loinc.orgVasopressin [Moles/volume] in Plasma --10th specimen post XXX challenge
  100814-3http://loinc.orgVasopressin [Moles/volume] in Plasma --11th specimen post XXX challenge
  100815-0http://loinc.orgVasopressin [Moles/volume] in Plasma --12th specimen post XXX challenge
  100816-8http://loinc.orgGlucagon [Mass/volume] in Serum or Plasma --6th specimen post XXX challenge
  100817-6http://loinc.orgGlucagon [Mass/volume] in Serum or Plasma --7th specimen post XXX challenge
  10081-8http://loinc.orgS' wave duration in lead V6
  100818-4http://loinc.orgRenin [Mass/volume] in Plasma --1st specimen post XXX challenge
  100819-2http://loinc.orgRenin [Mass/volume] in Plasma --2nd specimen post XXX challenge
  1008-2http://loinc.orgIndirect antiglobulin test.polyspecific reagent [Presence] in Serum or Plasma
  100820-0http://loinc.orgRenin [Mass/volume] in Plasma --3rd specimen post XXX challenge
  100821-8http://loinc.orgNational POLST form: portable medical order panel
  100822-6http://loinc.orgCardiopulmonary resuscitation orders
  100823-4http://loinc.orgInitial portable medical treatment orders
  100824-2http://loinc.orgAdditional portable medical orders or instructions
  100825-9http://loinc.orgMedically assisted nutrition orders
  10082-6http://loinc.orgST initial amplitude 6 ms in lead AVF
  100826-7http://loinc.orgPortable medical order AndOr advance directive review
  100827-5http://loinc.orgPortable medical order discussion participants
  100828-3http://loinc.orgPortable medical order administrative information
  100829-1http://loinc.orgRenin [Mass/volume] in Plasma --4th specimen post XXX challenge
  100830-9http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --1st specimen post XXX challenge
  100831-7http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --2nd specimen post XXX challenge
  100832-5http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --3rd specimen post XXX challenge
  100833-3http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --4th specimen post XXX challenge
  10083-4http://loinc.orgST initial amplitude 6 ms in lead AVL
  100834-1http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --5th specimen post XXX challenge
  100835-8http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --6th specimen post XXX challenge
  100836-6http://loinc.orgAlpha subunit free [Units/volume] in Serum or Plasma --7th specimen post XXX challenge
  100837-4http://loinc.orgInsulin-like growth factor-I [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
  100838-2http://loinc.orgTestosterone [Mass/volume] in Serum or Plasma --9th specimen post XXX challenge
  100839-0http://loinc.orgVitamin A/Retinol binding protein [Ratio] in Serum or Plasma
  100840-8http://loinc.orgIgE [Units/volume] in Body fluid
  100841-6http://loinc.orgZinc finger protein of the cerebellum 4 Ab [Presence] in Cerebral spinal fluid by Line blot
  10084-2http://loinc.orgST initial amplitude 6 ms in lead AVR
  100842-4http://loinc.orgNonalcoholic steatohepatitis score in Serum or Plasma Calculated by FAST
  100843-2http://loinc.orgLiver fibrosis score in Serum or Plasma by Calculated.Agile3+
  100844-0http://loinc.orgLiver fibrosis score in Serum or Plasma by Calculated.Agile4
  100845-7http://loinc.orgNeurofascin155 IgG4 Ab [Presence] in Serum by Flow cytometry (FC)
  100846-5http://loinc.orgDengue virus 1+2+3+4 nsP1 IgG Ab [Presence] in Serum or Plasma by Immunoassay
  100847-3http://loinc.orgGas and ammonia panel - Arterial blood
  100848-1http://loinc.orgCell count and Differential panel - Amniotic fluid by Manual count
  100849-9http://loinc.orgLeukocytes [#/volume] in Amniotic fluid by Manual count
  100850-7http://loinc.orgNeutrophils [#/volume] in Amniotic fluid by Manual count
  100851-5http://loinc.orgOther cells [#/volume] in Amniotic fluid by Manual count
  100852-3http://loinc.orgNM Bones Views for metastasis W Sr-89 IV
  100853-1http://loinc.orgNM Pericardial space Pericardial effusion
  100854-9http://loinc.orgLymphocytes/100 cells in Blood mononuclear cells by Immunoassay
  100855-6http://loinc.orgCD3 cells/100 cells in Blood mononuclear cells
  100856-4http://loinc.orgCD3+CD4+ (T4 helper) cells/100 cells in Blood mononuclear cells
  100857-2http://loinc.orgCD3+CD8+ (T8 suppressor) cells/100 cells in Blood mononuclear cells
  100858-0http://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  10085-9http://loinc.orgST initial amplitude 6 ms in lead I
  100859-8http://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100860-6http://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Spike peptide
  100861-4http://loinc.orgCells.CD4+CD154+/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100862-2http://loinc.orgCells.CD4.Interferon gamma-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100863-0http://loinc.orgCells.CD4.Tumor necrosis factor alfa-expressing/CD4 cells in Blood --after stimulation with SARS-CoV-2 Nucleocapsid peptide
  100864-8http://loinc.orgGiardia lamblia bg gene [Genotype] in Specimen by Molecular genetics method
  100865-5http://loinc.orgAvian schistosomes DNA [Presence] in Specimen by NAA with probe detection
  100866-3http://loinc.orgFebrile antibody profile in Serum
  10086-7http://loinc.orgST initial amplitude 6 ms in lead II
  100867-1http://loinc.orgCampylobacter jejuni+coli+lari+upsaliensis Ag [Presence] in Stool by Rapid immunoassay
  100868-9http://loinc.orgCryptosporidium sp 18S-LC2 rRNA [Genotype] in Specimen by Molecular genetics method
  100869-7http://loinc.orgCryptosporidium gp60 gene [Type] in Specimen by Molecular genetics method
  100870-5http://loinc.orgCryptosporidium 18S rRNA [Genotype] in Specimen by Molecular genetics method
  100871-3http://loinc.orgGiardia lamblia gdh gene [Genotype] in Specimen by Molecular genetics method
  100872-1http://loinc.orgBacteria producing polysaccharide from sucrose [Presence] in Isolate
  100873-9http://loinc.orgGiardia lamblia tpi gene [Genotype] in Specimen by Molecular genetics method
  100874-7http://loinc.orgBasidiobolus sp [Presence] in Specimen
  10087-5http://loinc.orgST initial amplitude 6 ms in lead III
  100875-4http://loinc.orgFetal Heart Document limited US
  100876-2http://loinc.orgFetal Heart Document US
  100877-0http://loinc.orgUS Heart Transesophageal during surgery
  100878-8http://loinc.orgEndoscopic ultrasound study Upper GI tract Document
  100879-6http://loinc.orgUS Guidance for cryoablation of Breast - right
  100880-4http://loinc.orgUS Guidance for cryoablation of Breast - left
  100881-2http://loinc.orgMR Guidance for cryoablation of Bone
  100882-0http://loinc.orgMR Peritoneum W contrast percutaneous intraperitoneal
  10088-3http://loinc.orgST initial amplitude 6 ms in lead V1
  100883-8http://loinc.orgMR Guidance for biopsy of Kidney - left
  100884-6http://loinc.orgMR Guidance for biopsy of Kidney - right
  100885-3http://loinc.orgParapoxvirus DNA [Presence] in Specimen by NAA with probe detection
  100886-1http://loinc.orgOrf virus DNA [Presence] in Specimen by NAA with probe detection
  100887-9http://loinc.orgPseudocowpox virus DNA [Presence] in Specimen by NAA with probe detection
  100888-7http://loinc.orgMonkeypox virus clade II DNA [Presence] in Specimen by NAA with probe detection
  100889-5http://loinc.orgMonkeypox virus clade I DNA [Presence] in Specimen by NAA with probe detection
  100890-3http://loinc.orgPoxvirus DNA panel
  10089-1http://loinc.orgST initial amplitude 6 ms in lead V2
  100891-1http://loinc.orgOrthopoxvirus IgG Ab [Presence] in Serum or Plasma by Immunoassay
  100892-9http://loinc.orgOrthopoxvirus IgM Ab [Presence] in Serum or Plasma by Immunoassay
  100893-7http://loinc.orgOrthopoxvirus IgG and IgM Ab panel - Serum or Plasma
  100894-5http://loinc.orgRecommended screening frequency Narrative
  100895-2http://loinc.orgRickettsia conorii IgG and IgM [Interpretation] in Serum
  100896-0http://loinc.orgVasopressin [Moles/volume] in Plasma --13th specimen post XXX challenge
  100897-8http://loinc.orgStaphylococcus aureus [Presence] in Specimen by Organism specific culture
  100898-6http://loinc.orgLipid panel - Serum or Plasma
  100899-4http://loinc.orgEnterobacteriaceae.extended spectrum beta lactamase resistance phenotype [Identifier] in Specimen by Organism specific culture

Explanation of the columns that may appear on this page:

Level A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies
System The source of the definition of the code (when the value set draws in codes defined elsewhere)
Code The code (used as the code in the resource instance)
Display The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application
Definition An explanation of the meaning of the concept
Comments Additional notes about how to use the code

History

DateActionCustodianAuthorComment
2023-11-14reviseTSMGMarc DuteauAdd standard copyright and contact to internal content; up-476
2022-10-18reviseTSMGMarc DuteauFixing missing metadata; up-349
2020-05-06reviseVocabulary WGTed KleinMigrated to the UTG maintenance environment and publishing tooling.
2014-03-26revise2014T1_2014-03-26_001283 (RIM release ID)Vocabulary (Woody Beeler) (no record of original request)Lock all vaue sets untouched since 2014-03-26 to trackingId 2014T1_2014_03_26